BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31055607)

  • 1. Chrysophanol, an anthraquinone from AST2017-01, possesses the anti-proliferative effect through increasing p53 protein levels in human mast cells.
    Han NR; Kim HY; Kang S; Kim MH; Yoon KW; Moon PD; Kim HM; Jeong HJ
    Inflamm Res; 2019 Jul; 68(7):569-579. PubMed ID: 31055607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of anti-inflammatory effect of chrysophanol, an active component of AST2017-01 on atopic dermatitis in vitro models.
    Jeong HJ; Kim HY; Kim HM
    Int Immunopharmacol; 2018 Jan; 54():238-244. PubMed ID: 29161660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory effects of chrysophanol, a bioactive compound of AST2017-01 in a mouse model of 2,4-dinitrofluorobenzene-induced atopic dermatitis.
    Han NR; Moon PD; Yoo MS; Ryu KJ; Kim HM; Jeong HJ
    Int Immunopharmacol; 2018 Sep; 62():220-226. PubMed ID: 30025384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptanthrin reduces mast cell proliferation promoted by TSLP through modulation of MDM2 and p53.
    Han NR; Kim HM; Jeong HJ
    Biomed Pharmacother; 2016 Apr; 79():71-7. PubMed ID: 27044814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ameliorative effect of AST2017-01 in an ovalbumin-induced allergic rhinitis animal model.
    Kim HY; Jee H; Yeom JH; Jeong HJ; Kim HM
    Inflamm Res; 2019 May; 68(5):387-395. PubMed ID: 30874868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cordycepin diminishes thymic stromal lymphopoietin-induced interleukin-13 production.
    Yoou MS; Yoon KW; Choi Y; Kim HM; Jeong HJ
    Eur J Pharmacol; 2017 May; 802():1-6. PubMed ID: 28219709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of atractylenolide III in the mast cell proliferation induced by TSLP.
    Yoou MS; Nam SY; Jin MH; Lee SY; Kim MS; Roh SS; Choi IH; Woo N; Lim S; Kim DH; Jang JB; Kim HM; Jeong HJ
    Food Chem Toxicol; 2017 Aug; 106(Pt A):78-85. PubMed ID: 28545868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of naringenin via IL-13 level regulation on thymic stromal lymphopoietin-induced inflammatory reactions.
    Han NR; Moon PD; Ryu KJ; Kim NR; Kim HM; Jeong HJ
    Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):362-369. PubMed ID: 29193236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acteoside attenuates TSLP-induced mast cell proliferation via down-regulating MDM2.
    Yoou MS; Kim HM; Jeong HJ
    Int Immunopharmacol; 2015 May; 26(1):23-9. PubMed ID: 25773666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new therapeutic herbal drug HM0601 and its bioactive compound rutin exert potent antiproliferative activities in mast cells.
    Jeong HJ; Yoou MS; Han NR; Hwang SY; Yoon KW; Kim HM
    Fundam Clin Pharmacol; 2018 Jun; 32(3):279-287. PubMed ID: 29368407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MDM2 expression by rosmarinic acid in TSLP-stimulated mast cell.
    Yoou MS; Park CL; Kim MH; Kim HM; Jeong HJ
    Eur J Pharmacol; 2016 Jan; 771():191-8. PubMed ID: 26694802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc Oxide Nanoparticles Demoted MDM2 Expression to Suppress TSLP-Induced Mast Cell Proliferation.
    Kim MH; Jeong HJ
    J Nanosci Nanotechnol; 2016 Mar; 16(3):2492-8. PubMed ID: 27455660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANKL down-regulates the mast cell proliferation through inducing senescence.
    Lim JH; Kim HY; Kang HG; Jeong HJ; Kim HM
    Cytokine; 2022 Nov; 159():156018. PubMed ID: 36054965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential anti-proliferative effect of β-sitosterol on human mast cell line-1 cells.
    Han NR; Kim HM; Jeong HJ
    Can J Physiol Pharmacol; 2015 Nov; 93(11):979-83. PubMed ID: 26314340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen sulfide diminishes the levels of thymic stromal lymphopoietin in activated mast cells.
    Han NR; Moon PD; Jeong HJ; Kim HM
    Arch Dermatol Res; 2016 Mar; 308(2):103-13. PubMed ID: 26791024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSLP induces mast cell development and aggravates allergic reactions through the activation of MDM2 and STAT6.
    Han NR; Oh HA; Nam SY; Moon PD; Kim DW; Kim HM; Jeong HJ
    J Invest Dermatol; 2014 Oct; 134(10):2521-2530. PubMed ID: 24751726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin Suppresses Thymic Stromal Lymphopoietin Expression via Blocking Caspase-1 and Receptor-Interacting Protein 2 Signaling Pathways in Mast Cells.
    Yoou MS; Jin MH; Lee SY; Lee SH; Kim B; Roh SS; Choi IH; Lee MS; Kim HM; Jeong HJ
    Biol Pharm Bull; 2016; 39(1):90-6. PubMed ID: 26725432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src-type tyrosine kinase p56lck is critical for thymic stromal lymphopoietin-induced allergic rhinitis.
    Nam SY; Kim HY; Han NR; Moon PD; Cho JS; Kim HM; Jeong HJ
    Clin Exp Allergy; 2018 Jul; 48(7):875-889. PubMed ID: 29752758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum-doped zinc oxide nanoparticles attenuate the TSLP levels via suppressing caspase-1 in activated mast cells.
    Kim MH; Seo JH; Kim HM; Jeong HJ
    J Biomater Appl; 2016 Apr; 30(9):1407-16. PubMed ID: 26825457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroquine attenuates thymic stromal lymphopoietin production via suppressing caspase-1 signaling in mast cells.
    Han NR; Ko SG; Moon PD; Park HJ
    Biomed Pharmacother; 2021 Sep; 141():111835. PubMed ID: 34146852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.